首頁 > 市場調查報告書 > 醫療設備

生技設備 3D列印

市場調查報告書

商品編碼

1547587

全球 3D 生物列印市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global 3D Bioprinting Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 127 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計全球 3D 生物列印市場需求將從 2023 年的 27.9 億美元增至 2032 年的近 83.8 億美元，2024-2032 年研究期間複合年成長率為 13.02%。

3D生物列印是一種先進技術，涉及生物材料、細胞和生長因子的逐層沉積，以創建模仿生物組織和器官的3D結構。它能夠精確製造具有可自訂屬性（例如形狀、尺寸和成分）的複雜生物結構，適用於組織工程、再生醫學和藥物測試。它承諾透過提供個人化的組織和器官替代品、減少器官移植的需求以及解決捐贈器官的短缺問題，徹底改變醫療保健領域。該領域的研究重點是改進列印技術、生物墨水配方和組織成熟過程，以增強生物列印結構的功能和可行性。

市場動態

推動 3D 生物列印市場的因素包括對個人化醫療的需求不斷成長、生物列印技術的進步以及慢性病和器官衰竭的流行。個人化醫療可根據患者的個別需求客製化治療方案，透過 3D 生物列印可以創建患者特定的組織和器官，從而顯著受益。這種方法在再生醫學和器官移植中特別有價值，因為捐贈器官的短缺仍然是一個關鍵問題。改進的生物墨水和更精確的印刷技術等進步也在推動市場向前發展。這些創新允許生產具有更高準確性和功能的複雜組織結構，從而增強生物列印產品的治療潛力。此外，糖尿病和心血管疾病等慢性疾病的成長增加了對組織工程解決方案的需求，從而推動了3D生物列印市場的發展。研究機構和生物列印公司之間的合作促進創新並加速生物列印組織和器官的商業化，進一步推動市場成長。然而，道德問題和監管挑戰可能會阻礙未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球 3D 生物列印市場的各個細分市場進行了包容性評估。 3D 生物列印產業的成長和趨勢為本研究提供了整體方法。

市場區隔

3D 生物列印市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

依技術

磁浮
基於噴墨
基於注射器
基於雷射
其他

按申請

醫療（組織和器官生成、藥丸、義肢和植入物、其他）
牙科
生物感測器
消費者/個人產品測試
生物墨水
食品和動物產品

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲 3D 生物列印市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。 3D生物列印市場的主要參與者包括Envisiontec Inc.、Organovo Holdings Inc.、Inventia Life Science PTY LTD、Poietis、Vivax Bio LLC、Allevi、Cyfuse Biomedical KK、3D Bioprinting Solutions、Celllink Global、Regemat 3D SL。的整體看法，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

Covid-19 爆發的影響分析
- 對生產的直接影響
- 供應鍊和市場擾亂
- 對公司和金融市場的財務影響
按生產、進口、出口和需求分類的 COVID-19 影響分析
市場：COVID-19 前 V/S 後
冠狀病毒 (COVID-19) 疫情的預期影響
COVID-19：微觀和宏觀因素分析

第 6 章：全球 3D 生物列印市場分析：按技術分類

依技術概述
歷史和預測數據
依技術分析
磁浮市場：按地區
噴墨市場：按地區分類
基於注射器的市場：按地區
雷射市場：按地區分類
其他市場：按地區

第 7 章：全球 3D 生物列印市場分析：按應用分類

概述：按應用
歷史和預測數據
分析：按應用
醫療市場：按地區
牙科市場：按地區
生物感測器市場：按地區
消費者/個人產品測試市場：按地區
生物墨水市場：按地區
食品和動物產品市場：按地區

第 8 章：全球 3D 生物列印市場分析：按地理位置

區域展望
介紹
北美洲
- 概覽、歷史和預測數據
- 北美按細分市場
- 北美洲：依國家分類
- 美國
- 加拿大
- 墨西哥
歐洲
- 概覽、歷史和預測數據
- 歐洲按細分市場
- 歐洲 : 按國家/地區
- 英國
- 法國
- 德國
- 義大利
- 俄羅斯
- 歐洲其他地區
亞太地區
- 概覽、歷史和預測數據
- 亞太地區（按細分市場）
- 亞太地區：依國家分類
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 亞太其他地區
拉丁美洲
- 概覽、歷史和預測數據
- 拉丁美洲按細分市場
- 拉丁美洲 : 依國家分類
- 巴西
- 阿根廷
- 秘魯
- 智利
- 拉丁美洲其他地區
中東和非洲
- 概覽、歷史和預測數據
- 中東和非洲（按細分市場）
- 中東和非洲：按國家/地區
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 南非
- 中東和非洲其他地區

第 9 章：3D 生物列印公司的競爭格局

3D生物列印市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Envisiontec, Inc.

公司概況
產品
最新動態

Inventia Life Science PTY LTD

公司概況
產品
最新動態

Organovo Holdings, Inc.

公司概況
產品
最新動態

Vivax Bio

公司概況
產品
最新動態

公司概況
產品
最新動態

3D Bioprinting Solutions

公司概況
產品
最新動態

Regemat 3D SL

公司概況
產品
最新動態

Poietis

公司概況
產品
最新動態

AlleviCyfuse Biomedical KK

公司概況
產品
最新動態

Cellink Global

公司概況
產品
最新動態

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR11214611

The global demand for 3D Bioprinting Market is presumed to reach the market size of nearly USD 8.38 Billion by 2032 from USD 2.79 Billion in 2023 with a CAGR of 13.02% under the study period 2024-2032.

3D bioprinting is an advanced technique that involves the layer-by-layer deposition of biomaterials, cells, and growth factors to create three-dimensional structures mimicking biological tissues and organs. It enables the precise fabrication of complex biological constructs with customizable properties, such as shape, size, and composition, for applications in tissue engineering, regenerative medicine, and drug testing. It promises to revolutionize healthcare by providing personalized tissue and organ replacements, reducing the need for organ transplants, and addressing the shortage of donor organs. Research in this field focuses on improving printing techniques, bioink formulations, and tissue maturation processes to enhance the functionality and viability of bioprinted constructs.

MARKET DYNAMICS

Factors driving the 3D bioprinting market include the increasing demand for personalized medicine, advancements in bioprinting technologies, and the spurring prevalence of chronic diseases and organ failures. Personalized medicine, which tailors treatments to individual patient needs, benefits significantly from 3D bioprinting by enabling the creation of patient-specific tissues and organs. This approach is particularly valuable in regenerative medicine and organ transplantation, where the shortage of donor organs remains a critical issue. Advancements, such as improved bioinks and more precise printing techniques, are also propelling the market forward. These innovations allow for the production of complex tissue structures with greater accuracy and functionality, enhancing the therapeutic potential of bioprinted products. Furthermore, the growth in chronic diseases such as diabetes & cardiovascular diseases increases the demand for tissue engineering solutions, thereby boosting the 3D bioprinting market. Collaborations between research institutions and bioprinting companies foster innovation and accelerate the commercialization of bioprinted tissues and organs, further driving the market growth. However, ethical concerns and regulatory challenges may hinder the market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of 3D Bioprinting. The growth and trends of 3D Bioprinting industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the 3D Bioprinting market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Magnetic Levitation
Inkjet-based
Syringe-based
Laser-based
Others

By Application

Medical (Tissue And Organ Generation, Medical Pills, Prosthetics And Implants, Others)
Dental
Biosensors
Consumer/Personal Product Testing
Bioinks
Food And Animal Product

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the 3D Bioprinting market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the 3D Bioprinting market include Envisiontec Inc., Organovo Holdings Inc., Inventia Life Science PTY LTD, Poietis, Vivax Bio LLC, Allevi, Cyfuse Biomedical K.K., 3D Bioprinting Solutions, Cellink Global, Regemat 3D S.L. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . 3D BIOPRINTING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 By Technology
- 3.7.2 By Application
- 3.7.3 By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

5.1. Impact Analysis of Covid-19 Outbreak
- 5.1.1. Direct Impact on Production
- 5.1.2. Supply Chain and Market Disruption
- 5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL 3D BIOPRINTING MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Magnetic Levitation Market by Regions
6.6 Inkjet-based Market by Regions
6.5 Syringe-based Market by Regions
6.7 Laser-based Market by Regions
6.8 Others Market by Regions

7 . GLOBAL 3D BIOPRINTING MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Medical Market by Regions
7.5 Dental Market by Regions
7.6 Biosensors Market by Regions
7.7 Consumer/Personal Product Testing Market by Regions
7.8 Bioinks Market by Regions
7.9 Food and Animal Product Market by Regions

8 . GLOBAL 3D BIOPRINTING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America
- 8.3.1. Overview, Historic and Forecast Data
- 8.3.2. North America By Segment
- 8.3.3. North America By Country
- 8.3.4. United State
- 8.3.5. Canada
- 8.3.6. Mexico
8.4. Europe
- 8.4.1. Overview, Historic and Forecast Data
- 8.4.2. Europe by Segment
- 8.4.3. Europe by Country
- 8.4.4. United Kingdom
- 8.4.5. France
- 8.4.6. Germany
- 8.4.7. Italy
- 8.4.8. Russia
- 8.4.9. Rest Of Europe
8.5. Asia Pacific
- 8.5.1. Overview, Historic and Forecast Data
- 8.5.2. Asia Pacific by Segment
- 8.5.3. Asia Pacific by Country
- 8.5.4. China
- 8.5.5. India
- 8.5.6. Japan
- 8.5.7. South Korea
- 8.5.8. Australia
- 8.5.9. Rest Of Asia Pacific
8.6. Latin America
- 8.6.1. Overview, Historic and Forecast Data
- 8.6.2. Latin America by Segment
- 8.6.3. Latin America by Country
- 8.6.4. Brazil
- 8.6.5. Argentina
- 8.6.6. Peru
- 8.6.7. Chile
- 8.6.8. Rest of Latin America
8.7. Middle East & Africa
- 8.7.1. Overview, Historic and Forecast Data
- 8.7.2. Middle East & Africa by Segment
- 8.7.3. Middle East & Africa by Country
- 8.7.4. Saudi Arabia
- 8.7.5. UAE
- 8.7.6. Israel
- 8.7.7. South Africa
- 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE 3D BIOPRINTING COMPANIES

9.1. 3D Bioprinting Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF 3D BIOPRINTING INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Envisiontec, Inc.
- 10.3.1. Company Overview
- 10.3.2. Financials
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Inventia Life Science PTY LTD
- 10.4.1. Company Overview
- 10.4.2. Financials
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Organovo Holdings, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financials
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Vivax Bio
- 10.6.1. Company Overview
- 10.6.2. Financials
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. LLC
- 10.7.1. Company Overview
- 10.7.2. Financials
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. 3D Bioprinting Solutions
- 10.8.1. Company Overview
- 10.8.2. Financials
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Regemat 3D S.L.
- 10.9.1. Company Overview
- 10.9.2. Financials
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Poietis
- 10.10.1. Company Overview
- 10.10.2. Financials
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. AlleviCyfuse Biomedical K.K.
- 10.11.1. Company Overview
- 10.11.2. Financials
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Cellink Global
- 10.12.1. Company Overview
- 10.12.2. Financials
- 10.12.3. Products
- 10.12.4. Recent Developments